Descartes-08 - Cartesian Therapeutics
Recent Pipeline Progress and Anticipated Milestones (GlobeNewswire) - Nov 6, 2025 - "Preliminary Data from Ongoing Phase 2 Open-Label Trial of Descartes-08 in Patients with SLE Expected by End of Year...Phase 2 Pediatric Basket Trial of Descartes-08 in Select Autoimmune Diseases Expected to Initiate by End of Year." 
New P2 trial • P2 data Immunology • Systemic Lupus Erythematosus
https://www.globenewswire.com/news-release/2025/11/06/3182390/0/en/Cartesian-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
 
Nov 6, 2025